LifeMD (NASDAQ:LFMDP) Stock Price Down 1.8% – Should You Sell?

LifeMD, Inc. (NASDAQ:LFMDPGet Free Report) was down 1.8% during mid-day trading on Friday . The company traded as low as $21.75 and last traded at $21.86. Approximately 4,652 shares were traded during trading, an increase of 89% from the average daily volume of 2,465 shares. The stock had previously closed at $22.25.

LifeMD Price Performance

The firm’s fifty day simple moving average is $22.51 and its 200 day simple moving average is $22.29.

LifeMD Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, January 15th. Shareholders of record on Friday, January 3rd were issued a $0.5547 dividend. This represents a $2.22 dividend on an annualized basis and a yield of 10.15%. The ex-dividend date of this dividend was Friday, January 3rd.

About LifeMD

(Get Free Report)

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.

Read More

Receive News & Ratings for LifeMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeMD and related companies with MarketBeat.com's FREE daily email newsletter.